OncoSignal

Marco Ladetto

Dipartimento Medicina Traslazionale, Università del Piemonte Orientale - S.C. Ematologia ed Infrastruttura Ricerca Formazione ed Innovazione, A.O. SS. Antonio e Biagio e C. Arrigo (Alessandria, Italy) · Department of Translational Medicine of the Università degli Studi del Piemonte Orientale, Novara, Italy. AO SS Antonio e Biagio e C. Arrigo, Alessandria, Italy. · AO SS Antonio e Biagio e Cesare Arrigo, Alessandria

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official
6
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
48
PubMed author-name match

Trials

Studies that name Marco Ladetto as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:55 UTC. Open this list on ClinicalTrials.gov

Grants

NIH projects from RePORTER, fetched 2026-11-12 01:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

Most cited trial papers

Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:55 UTC. The ranking covers the 200 most relevant of 48 PubMed records, and a shared surname and initials can bring in a namesake. All 48 on PubMed

  1. 217 citations
    RCR 5.5
  2. 197 citations
    RCR 4.4
  3. 150 citations
    RCR 4.0
  4. 144 citations
    RCR 18.2
  5. 113 citations
    RCR 4.4
  6. 112 citations
    RCR 3.7
  7. 101 citations
    RCR 2.1
  8. 87 citations
    RCR 6.0
  9. 78 citations
    RCR 1.6
  10. 78 citations
    RCR 2.1